BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16435014)

  • 21. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.
    Schrauder A; Reiter A; Gadner H; Niethammer D; Klingebiel T; Kremens B; Peters C; Ebell W; Zimmermann M; Niggli F; Ludwig WD; Riehm H; Welte K; Schrappe M
    J Clin Oncol; 2006 Dec; 24(36):5742-9. PubMed ID: 17179108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retroviral transduction of IL-7Ralpha into IL-7Ralpha-/- bone marrow progenitors: correction of lymphoid deficiency and induction of neutrophilia.
    Jiang Q; Li WQ; Aiello FB; Klarmann KD; Keller JR; Durum SK
    Gene Ther; 2005 Dec; 12(24):1761-8. PubMed ID: 16208423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation.
    Carvalho A; Cunha C; Di Ianni M; Pitzurra L; Aloisi T; Falzetti F; Carotti A; Bistoni F; Aversa F; Romani L
    Bone Marrow Transplant; 2010 Nov; 45(11):1645-52. PubMed ID: 20173782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythroid-lineage-specific engraftment in patients with severe hemoglobinopathy following allogeneic hematopoietic stem cell transplantation.
    Armistead PM; Mohseni M; Gerwin R; Walsh EC; Iravani M; Chahardouli B; Rostami S; Zhang W; Neuberg D; Rioux J; Ghavamzadeh A; Ritz J; Antin JH; Wu CJ
    Exp Hematol; 2008 Sep; 36(9):1205-15. PubMed ID: 18550258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
    Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
    Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms in cytokine genes influence long-term survival differently in elderly male and female patients.
    Cederholm T; Persson M; Andersson P; Stenvinkel P; Nordfors L; Madden J; Vedin I; Wretlind B; Grimble RF; Palmblad J
    J Intern Med; 2007 Aug; 262(2):215-23. PubMed ID: 17645589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-10 gene polymorphism in bone marrow transplant recipients.
    Azarpira N; Ramzi M; Aghdaie MH; Darai M; Geramizadeh B
    Exp Clin Transplant; 2008 Mar; 6(1):74-9. PubMed ID: 18405249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].
    Dou LP; DA WM; Zhao DD; Wang C; Lu XC; Kang HY; Yan P; Wang FF; Zhu HY; Li HH; Gao CJ; Yu L
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3111-4. PubMed ID: 18269867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association between multidrug resistance-1 gene polymorphisms and outcomes of allogeneic HLA-identical stem cell transplantation.
    Kim DH; Park JY; Sohn SK; Lee NY; Suh JS; Lee KB
    Haematologica; 2006 Jun; 91(6):848-51. PubMed ID: 16769591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms in the immunoregulatory genes are associated with hematopoietic recovery and increased susceptibility to bacterial infections in patients with thalassaemia major undergoing matched related hematopoietic stem cell transplantation.
    Sellathamby S; Lakshmi KM; Busson M; Viswabandya A; George B; Mathews V; Chandy M; Charron D; Krishnamoorthy R; Tamouza R; Srivastava A
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1219-26. PubMed ID: 22252124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An association study of inflammatory cytokine gene polymorphisms in Fabry disease.
    Safyan R; Whybra C; Beck M; Elstein D; Altarescu G
    Eur Cytokine Netw; 2006 Dec; 17(4):271-5. PubMed ID: 17353161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma.
    Wei YS; Lan Y; Luo B; Lu D; Nong HB
    Mol Carcinog; 2009 Aug; 48(8):751-7. PubMed ID: 19148899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
    Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
    Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation.
    Granell M; Urbano-Ispizua A; Suarez B; Rovira M; Fernández-Avilés F; Martínez C; Ortega M; Uriburu C; Gaya A; Roncero JM; Navarro A; Carreras E; Mensa J; Vives J; Rozman C; Montserrat E; Lozano F
    Exp Hematol; 2006 Oct; 34(10):1435-41. PubMed ID: 16982337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?
    Mehta J; Gordon LI; Tallman MS; Winter JN; Evens AM; Frankfurt O; Williams SF; Grinblatt D; Kaminer L; Meagher R; Singhal S
    Bone Marrow Transplant; 2006 Jul; 38(2):95-100. PubMed ID: 16751789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma.
    Snoussi K; Strosberg AD; Bouaouina N; Ben Ahmed S; Chouchane L
    Eur Cytokine Netw; 2005 Dec; 16(4):253-60. PubMed ID: 16464738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine gene polymorphism in kidney transplantation--impact of TGF-beta 1, TNF-alpha and IL-6 on graft outcome.
    Nikolova PN; Ivanova MI; Mihailova SM; Myhailova AP; Baltadjieva DN; Simeonov PL; Paskalev EK; Naumova EJ
    Transpl Immunol; 2008 Feb; 18(4):344-8. PubMed ID: 18158121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.